BHUBANESWAR: Passing internal assessment and project examination will now be mandatory for all Plus II final year students.
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback